Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Stevceva

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Medicinal Chemistry|November 5, 2011
Toll-like receptor agonists as adjuvants for HIV vaccinesL Stevceva
Current Medicinal Chemistry|August 10, 2011
Update on HIV vaccines: which way now?L Stevceva
Current Pharmaceutical Design|March 22, 2005
Mucosal adjuvantsL Stevceva, M G Ferrari
Genes and Immunity|February 24, 2001
Targeting the mucosa: genetically engineered vaccines and mucosal immune responsesL Stevceva, A G Abimiku, G Franchini
Genes and Immunity|October 19, 2001
Dextran sulphate sodium-induced colitis is ameliorated in interleukin 4 deficient miceL Stevceva, P Pavli, A Husband, et al.
Journal of Gastroenterology and Hepatology|February 24, 1999
Dextran sodium sulphate-induced colitis activity varies with mouse strain but develops in lipopolysaccharide-unresponsive miceL Stevceva, P Pavli, G Buffinton, et al.
Current Medicinal Chemistry|January 22, 2010
The GP120 molecule of HIV-1 and its interaction with T cellsV Yoon, M Fridkis-Hareli, S Munisamy, et al.
Molecular Medicine Today|February 1, 2000
Recent advances with recombinant bacterial vaccine vectorsM T Shata, L Stevceva, S Agwale, et al.
BMC Infectious Diseases|August 16, 2001
Differences in time of virus appearance in the blood and virus-specific immune responses in intravenous and intrarectal primary SIVmac251 infection of rhesus macaques; a pilot studyL Stevceva, E Tryniszewska, Z Hel, et al.
Genes and Immunity|February 24, 2001
Eosinophilia is attenuated in experimental colitis induced in IL-5 deficient miceL Stevceva, P Pavli, A Husband, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Medicinal Chemistry|November 5, 2011
Toll-like receptor agonists as adjuvants for HIV vaccinesL Stevceva
Current Medicinal Chemistry|August 10, 2011
Update on HIV vaccines: which way now?L Stevceva
Current Pharmaceutical Design|March 22, 2005
Mucosal adjuvantsL Stevceva, M G Ferrari
Genes and Immunity|February 24, 2001
Targeting the mucosa: genetically engineered vaccines and mucosal immune responsesL Stevceva, A G Abimiku, G Franchini
Genes and Immunity|October 19, 2001
Dextran sulphate sodium-induced colitis is ameliorated in interleukin 4 deficient miceL Stevceva, P Pavli, A Husband, et al.
Journal of Gastroenterology and Hepatology|February 24, 1999
Dextran sodium sulphate-induced colitis activity varies with mouse strain but develops in lipopolysaccharide-unresponsive miceL Stevceva, P Pavli, G Buffinton, et al.
Current Medicinal Chemistry|January 22, 2010
The GP120 molecule of HIV-1 and its interaction with T cellsV Yoon, M Fridkis-Hareli, S Munisamy, et al.
Molecular Medicine Today|February 1, 2000
Recent advances with recombinant bacterial vaccine vectorsM T Shata, L Stevceva, S Agwale, et al.
BMC Infectious Diseases|August 16, 2001
Differences in time of virus appearance in the blood and virus-specific immune responses in intravenous and intrarectal primary SIVmac251 infection of rhesus macaques; a pilot studyL Stevceva, E Tryniszewska, Z Hel, et al.
Genes and Immunity|February 24, 2001
Eosinophilia is attenuated in experimental colitis induced in IL-5 deficient miceL Stevceva, P Pavli, A Husband, et al.
Pageof 2